Crocs, Inc. $CROX Shares Sold by Smead Capital Management Inc.

Smead Capital Management Inc. trimmed its holdings in Crocs, Inc. (NASDAQ:CROXFree Report) by 6.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 594,690 shares of the textile maker’s stock after selling 39,392 shares during the period. Crocs comprises approximately 1.1% of Smead Capital Management Inc.’s holdings, making the stock its 27th largest holding. Smead Capital Management Inc.’s holdings in Crocs were worth $50,858,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the business. NewEdge Advisors LLC raised its position in shares of Crocs by 1.1% in the 2nd quarter. NewEdge Advisors LLC now owns 10,710 shares of the textile maker’s stock valued at $1,085,000 after purchasing an additional 120 shares in the last quarter. Parallel Advisors LLC raised its position in shares of Crocs by 60.2% in the 3rd quarter. Parallel Advisors LLC now owns 495 shares of the textile maker’s stock valued at $41,000 after purchasing an additional 186 shares in the last quarter. Kestra Investment Management LLC raised its position in shares of Crocs by 7.2% in the 2nd quarter. Kestra Investment Management LLC now owns 2,800 shares of the textile maker’s stock valued at $284,000 after purchasing an additional 187 shares in the last quarter. Traub Capital Management LLC raised its position in shares of Crocs by 7.1% in the 4th quarter. Traub Capital Management LLC now owns 3,000 shares of the textile maker’s stock valued at $257,000 after purchasing an additional 200 shares in the last quarter. Finally, Belpointe Asset Management LLC raised its position in shares of Crocs by 4.7% in the 3rd quarter. Belpointe Asset Management LLC now owns 4,796 shares of the textile maker’s stock valued at $401,000 after purchasing an additional 216 shares in the last quarter. 93.44% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CROX has been the topic of a number of recent analyst reports. Piper Sandler reaffirmed a “neutral” rating and issued a $95.00 target price on shares of Crocs in a research report on Thursday, February 12th. The Goldman Sachs Group upped their target price on Crocs from $71.00 to $81.00 and gave the company a “sell” rating in a research report on Friday, February 13th. Barclays upped their price target on Crocs from $109.00 to $110.00 and gave the company an “equal weight” rating in a research report on Friday, May 1st. Wall Street Zen raised Crocs from a “hold” rating to a “buy” rating in a research report on Saturday, April 11th. Finally, Monness Crespi & Hardt upped their price target on Crocs from $100.00 to $130.00 and gave the company a “buy” rating in a research report on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $103.73.

View Our Latest Report on CROX

Crocs Stock Performance

CROX stock opened at $110.44 on Friday. The company has a current ratio of 1.67, a quick ratio of 1.04 and a debt-to-equity ratio of 0.93. The firm has a market cap of $5.49 billion, a P/E ratio of -80.03, a P/E/G ratio of 1.08 and a beta of 1.54. Crocs, Inc. has a 12-month low of $73.21 and a 12-month high of $113.16. The stock’s 50 day simple moving average is $94.25 and its 200 day simple moving average is $88.89.

Crocs (NASDAQ:CROXGet Free Report) last posted its quarterly earnings results on Thursday, April 30th. The textile maker reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.78 by $0.21. The business had revenue of $921.46 million for the quarter, compared to analyst estimates of $900.57 million. Crocs had a positive return on equity of 48.29% and a negative net margin of 2.58%.The business’s revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the company posted $3.00 EPS. Crocs has set its Q2 2026 guidance at 4.150-4.350 EPS and its FY 2026 guidance at 13.200-13.750 EPS. As a group, equities research analysts predict that Crocs, Inc. will post 13.67 EPS for the current year.

Crocs Profile

(Free Report)

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.

Read More

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROXFree Report).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.